anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

MARKET

IPO Synopsis
Surya Pharmaceutical Ltd
Registered Office: 1596 1st Floor, Bhagirath Palace, Delhi - 110006, Delhi
Phone: 1
Email: 1
Website: 1
Public issue of 3000000 equity shares of Rs 10/- each for cash at premium of Rs 35/- each aggregating Rs 13.50 crore.
Issue Money Payable On
Opens On Closes On Application Allotment
18-Dec-2003 22-Dec-2003 45.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 13.50
Project Financed through Current Offer 13.50
Post Issue Equity Share Capital 10.46
Issue Price 45.00
Projects
To augments working capital for its projects.
Meet capital expenditure on R&D.
Promoted By
Rajeev Goyal
Alka Goyal
Sushail Goyal
BSE
NSE
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.